- $52.54m
- $25.79m
- $80.02m
- 85
- 95
- 53
- 92
2018 December 31st | R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 74 | 75.5 | 69.8 | 75.6 | 80 |
Cost of Revenue | |||||
Gross Profit | 41.1 | 42.4 | 38.6 | 43.1 | 48.5 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 77.7 | 74.9 | 69.1 | 69.1 | 73 |
Operating Profit | -3.72 | 0.591 | 0.772 | 6.46 | 7.03 |
Total Net Non Operating Interest Income / Expense | |||||
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -4.12 | -0.271 | 0.357 | 6.25 | 7.13 |
Provision for Income Taxes | |||||
Net Income After Taxes | -3.73 | -0.382 | 0.358 | 6.1 | 11.9 |
Net Income Before Extraordinary Items | |||||
Net Income | -3.73 | -0.382 | 0.358 | 6.1 | 11.9 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -3.73 | -0.382 | 0.358 | 6.1 | 11.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.023 | -0.002 | 0.002 | 0.015 | 0.068 |